174 related articles for article (PubMed ID: 30987350)
1. Synthesis of Pyridine-Dicarboxamide-Cyclohexanone Derivatives: Anticancer and α-Glucosidase Inhibitory Activities and In Silico Study.
Al-Majid AM; Islam MS; Atef S; El-Senduny FF; Badria FA; Elshaier YAMM; Ali M; Barakat A; Motiur Rahman AFM
Molecules; 2019 Apr; 24(7):. PubMed ID: 30987350
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives.
Barakat A; Islam MS; Al-Majid AM; Ghabbour HA; Fun HK; Javed K; Imad R; Yousuf S; Choudhary MI; Wadood A
Bioorg Med Chem; 2015 Oct; 23(20):6740-8. PubMed ID: 26381063
[TBL] [Abstract][Full Text] [Related]
3. A concise synthesis and evaluation of new malonamide derivatives as potential α-glucosidase inhibitors.
Islam MS; Barakat A; Al-Majid AM; Ghabbour HA; Rahman AF; Javaid K; Imad R; Yousuf S; Choudhary MI
Bioorg Med Chem; 2016 Apr; 24(8):1675-82. PubMed ID: 26972921
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective Synthesis of the Di-Spirooxindole Analogs Based Oxindole and Cyclohexanone Moieties as Potential Anticancer Agents.
Al-Majid AM; Ali M; Islam MS; Alshahrani S; Alamary AS; Yousuf S; Choudhary MI; Barakat A
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684885
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
Gong Z; Xie Z; Qiu J; Wang G
Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
[TBL] [Abstract][Full Text] [Related]
6. Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity.
Abdel-Rahman AA; Shaban AKF; Nassar IF; El-Kady DS; Ismail NSM; Mahmoud SF; Awad HM; El-Sayed WA
Molecules; 2021 Jun; 26(13):. PubMed ID: 34206976
[TBL] [Abstract][Full Text] [Related]
7. An efficient and targeted synthetic approach towards new highly substituted 6-amino-pyrazolo[1,5-a]pyrimidines with α-glucosidase inhibitory activity.
Peytam F; Adib M; Shourgeshty R; Firoozpour L; Rahmanian-Jazi M; Jahani M; Moghimi S; Divsalar K; Faramarzi MA; Mojtabavi S; Safari F; Mahdavi M; Foroumadi A
Sci Rep; 2020 Feb; 10(1):2595. PubMed ID: 32054916
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies.
Saleem F; Kanwal ; Khan KM; Chigurupati S; Solangi M; Nemala AR; Mushtaq M; Ul-Haq Z; Taha M; Perveen S
Bioorg Chem; 2021 Jan; 106():104489. PubMed ID: 33272713
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors.
El-Adl K; El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Nasser M; Abulkhair HS; El-Hddad SSA
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000279. PubMed ID: 33073374
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors.
Wang G; Peng Z; Gong Z; Li Y
Bioorg Chem; 2018 Aug; 78():195-200. PubMed ID: 29587132
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of isatin derivatives containing 1,3,4-thiadiazole as potent a-glucosidase inhibitors.
Zhao X; Zhan X; Zhang H; Wan Y; Yang H; Wang Y; Chen Y; Xie W
Bioorg Med Chem Lett; 2021 Dec; 54():128447. PubMed ID: 34767915
[TBL] [Abstract][Full Text] [Related]
12. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
14. Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies.
Hu CM; Wang WJ; Ye YN; Kang Y; Lin J; Wu PP; Li DL; Bai LP; Xu XT; Li BQ; Zhang K
Bioorg Chem; 2021 Nov; 116():105291. PubMed ID: 34438122
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
16. Pyridine-derived VEGFR-2 inhibitors: Rational design, synthesis, anticancer evaluations, in silico ADMET profile, and molecular docking.
Saleh NM; Abdel-Rahman AA; Omar AM; Khalifa MM; El-Adl K
Arch Pharm (Weinheim); 2021 Aug; 354(8):e2100085. PubMed ID: 33948983
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro α-glucosidase inhibitory activity and molecular docking studies of new thiazole derivatives.
Khan KM; Qurban S; Salar U; Taha M; Hussain S; Perveen S; Hameed A; Ismail NH; Riaz M; Wadood A
Bioorg Chem; 2016 Oct; 68():245-58. PubMed ID: 27592296
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies.
Peytam F; Adib M; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Mahdavi M; Moghadamnia AA; Rastegar H; Larijani B
Mol Divers; 2020 Feb; 24(1):69-80. PubMed ID: 30825061
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Molecular Modeling and Biological Evaluation of 5-arylidene-N,N-diethylthiobarbiturates as Potential α-glucosidase Inhibitors.
Khan M; Khan S; Ul Mulk A; Ur Rahman A; Wadood A; Shams S; Ashraf M; Rahman J; Khan I; Hameed A; Hussain Z; Khan A; Zaman K; Khan KM; Perveen S
Med Chem; 2019; 15(2):175-185. PubMed ID: 30207240
[TBL] [Abstract][Full Text] [Related]
20. Novel Bis-Schiff's base derivatives of 4-nitroacetophenone as potent α-glucosidase agents: Design, synthesis and in silico approach.
Alam A; Ali M; Latif A; Rehman NU; Saher S; Zainab ; Faryal ; Khan A; Ullah S; Ullah O; Halim SA; Sani F; Al-Harrasi A; Ahmad M
Bioorg Chem; 2022 Nov; 128():106058. PubMed ID: 35917750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
